DeAngelo, D. J., Li, C., Verma, A., Severgnini, M., Nickle, D., Garcia-Manero, G., . . . Carlisle, S. (2023). 688 Transcriptome analyses in patients with myeloid malignances treated with the IRAK4 inhibitor emavusertib. BMJ Publishing Group.
Chicago Style (17th ed.) CitationDeAngelo, Daniel J., et al. 688 Transcriptome Analyses in Patients with Myeloid Malignances Treated with the IRAK4 Inhibitor Emavusertib. BMJ Publishing Group, 2023.
MLA (9th ed.) CitationDeAngelo, Daniel J., et al. 688 Transcriptome Analyses in Patients with Myeloid Malignances Treated with the IRAK4 Inhibitor Emavusertib. BMJ Publishing Group, 2023.
Warning: These citations may not always be 100% accurate.